The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment

NCT02590874 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Depression

Interventions

DRUG: Duloxetine
DRUG: Placebo

Sponsor

University of North Texas Health Science Center